These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 3807085)

  • 21. Determination of androgen, progestin and estrogen receptors with two different assays in renal cell carcinoma.
    Klötzl G; Otto U; Becker H; Klosterhalfen H
    Urol Int; 1987; 42(2):100-4. PubMed ID: 2441503
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase type II expression in renal cell neoplasms: a tissue microarray and quantitative RT-PCR study.
    Yakirevich E; Morris DJ; Tavares R; Meitner PA; Lechpammer M; Noble L; de Rodriguez AF; Gomez-Sanchez CE; Wang LJ; Sabo E; Delellis RA; Resnick MB
    Am J Surg Pathol; 2008 Jun; 32(6):874-83. PubMed ID: 18408592
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nephron-sparing surgery for de novo renal cell carcinoma in a 19-year-old transplanted kidney.
    De Simone P; Antonacci V; Rosa F; Verzaro R
    Transplantation; 2004 Feb; 77(3):478. PubMed ID: 14966434
    [No Abstract]   [Full Text] [Related]  

  • 24. Expression of vascular endothelial growth factor protein in human renal cell carcinoma.
    Turner K
    BJU Int; 2004 Sep; 94(4):678. PubMed ID: 15329141
    [No Abstract]   [Full Text] [Related]  

  • 25. [Medical perspectives of metabolomics: the example of renal carcinoma].
    Dormoy V; Massfelder T
    Med Sci (Paris); 2013 May; 29(5):463-8. PubMed ID: 23732093
    [No Abstract]   [Full Text] [Related]  

  • 26. The role of nephron sparing surgery for metastatic (pM1) renal cell carcinoma.
    Krambeck AE; Leibovich BC; Lohse CM; Kwon ED; Zincke H; Blute ML
    J Urol; 2006 Nov; 176(5):1990-5; discussion 1995. PubMed ID: 17070231
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Nephron-sparing surgery for renal tumors].
    Maksimov AV; Martov AG; Neustroev PA; Vinokurov RR
    Urologiia; 2018 Oct; (4):142-146. PubMed ID: 30761805
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nephron sparing surgery for renal cell carcinoma.
    Licht MR; Novick AC
    J Urol; 1993 Jan; 149(1):1-7. PubMed ID: 8417184
    [No Abstract]   [Full Text] [Related]  

  • 29. Beta-human Chorionic Gonadotropin-producing Renal Cell Carcinoma.
    Adekunle AN; Lam AS; Turbow SD; Stallworth CR; Ferris MJ; Kim J; Jacobson TA
    Am J Med; 2016 Mar; 129(3):e29-31. PubMed ID: 26582059
    [No Abstract]   [Full Text] [Related]  

  • 30. A novel entity: low-grade mucinous tubular renal carcinoma.
    Ferlicot S; Lupo A; Lazure T; Bedossa P; Vieillefond A
    Histopathology; 2005 Aug; 47(2):218-9. PubMed ID: 16045786
    [No Abstract]   [Full Text] [Related]  

  • 31. [Heterogeneity of human renal cell carcinoma. III. 1 alpha,25-dihydroxyvitamin D3 receptor and inhibition on the growth of renal carcinoma cell lines].
    Nagakura K
    Nihon Hinyokika Gakkai Zasshi; 1986 Jan; 77(1):92-7. PubMed ID: 3014194
    [No Abstract]   [Full Text] [Related]  

  • 32. Re: The Subclassification of Papillary Renal Cell Carcinoma Does Not Affect Oncological Outcomes after Nephron Sparing Surgery.
    Laguna MP
    J Urol; 2016 Sep; 196(3):686-7. PubMed ID: 27597059
    [No Abstract]   [Full Text] [Related]  

  • 33. Discovery of a novel target for renal cell carcinoma: transglutaminase 2.
    Kang JH; Lee SH; Kim SY
    Cell Death Dis; 2016 Apr; 7(4):e2200. PubMed ID: 27100894
    [No Abstract]   [Full Text] [Related]  

  • 34. Implications of insulin-like growth factors in renal cell carcinoma.
    Bennington JL; Strathearn M; Spencer EM; Williams RD
    Eur Urol; 1990; 18 Suppl 2():13-4. PubMed ID: 2226595
    [No Abstract]   [Full Text] [Related]  

  • 35. A study of growth factors in human renal cysts with or without renal cell carcinoma.
    Taide M; Kanda S; Eguchi J; Igawa T; Kanetake H; Saito Y
    Clin Chim Acta; 1993 Aug; 217(2):199-203. PubMed ID: 8261629
    [No Abstract]   [Full Text] [Related]  

  • 36. Laparoscopic tumorectomy of renal carcinoma recurred in remaining kidney.
    Cursio R; Choquenet C
    Minerva Chir; 2002 Aug; 57(4):507-8. PubMed ID: 12145583
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Re: Zhu et al.: The expression and evaluation of androgen receptor in human renal cell carcinoma (Urology 2014;83:510.e19-24).
    Putz J; Wirth MP; Froehner M; Jahn S
    Urology; 2014 Sep; 84(3):734-5. PubMed ID: 25168563
    [No Abstract]   [Full Text] [Related]  

  • 38. Kidney cancer: Tumour versus nephron gene expression yields survival score.
    Fenner A
    Nat Rev Urol; 2015 Aug; 12(8):415. PubMed ID: 26123041
    [No Abstract]   [Full Text] [Related]  

  • 39. Nephron sparing surgery for de novo kidney graft tumor: results from a multicenter national study.
    Goldfarb DA
    J Urol; 2015 Mar; 193(3):784. PubMed ID: 25765382
    [No Abstract]   [Full Text] [Related]  

  • 40. [A case of renal cell carcinoma of horseshoe kidney that produced AFP and caused hypercalcemia].
    Okada H; Kawabata G; Kamidono S; Ishigami J; Nakatsuka E
    Hinyokika Kiyo; 1984 Oct; 30(10):1453-8. PubMed ID: 6084418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.